Uterine Cancer Diagnostic Testing Market

Global Market Study on Uterine Cancer Diagnostic Testing: Endometrium Carcinoma Segment to Lead in Terms of Value Through 2026

Uterine Cancer Diagnostic Testing Market Segmented By Endometrial Carcinoma, Uterine Sarcoma Cancer Type by Abdominal Ultrasound Scanning, Transvaginal Ultrasound Scanning, Endometrial Biopsy, Hysteroscopy, Dilation and Curettage, Complete Blood Count, CA125 Marker Blood Test

  • September-2018
  • PMRREP17005
  • 241 Pages
  • Healthcare
  • PPT, PDF, WORD, EXCEL

Table of Content

1. Executive Summary
     1.1. Market Overview
     1.2. Market Analysis
     1.3. PMR Analysis and Recommendations
     1.4. Wheel of Fortune

2. Market Introduction
     2.1. Market Definition
     2.2. Market Taxonomy

3. Uterine Cancer Diagnostic Testing Market View Point
     3.1. Macro-Economic Factors
     3.2. Market Drivers and Restraints
     3.3. Opportunity Analysis
     3.4. Global Key trends
     3.5. Reimbursement Scenario

4. Global Uterine Cancer Diagnostic Testing Market – Key Inclusions
     4.1. Regional Average Pricing Analysis
     4.2. Parent Market Assessment
     4.3. Epidemiology

5. North America Uterine Cancer Diagnostic Testing Market Analysis 2013–2017 and Forecast 2018–2026
     5.1. Introduction
     5.2. Historical Market Size (US$ Mn) By Country, 2013-2017
            5.2.1. U.S.
            5.2.2. Canada
     5.3. Market Size (US$ Mn) Forecast By Country, 2018-2026
            5.3.1. U.S.
            5.3.2. Canada
     5.4. Historical Market Size (US$ Mn) By Cancer Type, 2013-2017
            5.4.1. Uterine Sarcoma
            5.4.2. Endometrial Carcinomas
     5.5. Market Size (US$ Mn) Forecast By Cancer Type, 2018-2026
            5.5.1. Uterine Sarcoma
            5.5.2. Endometrial Carcinomas
     5.6. Historical Market Size (US$ Mn) By Test Type, 2013-2017
            5.6.1. Ultrasound Scanning
                     5.6.1.1. Abdominal Ultrasound
                     5.6.1.2. Transvaginal Ultrasound
            5.6.2. Biopsy
                     5.6.2.1. Endometrial Biopsy
                     5.6.2.2. Hysteroscopy
                     5.6.2.3. Dilation and curettage
            5.6.3. Blood tests
                     5.6.3.1. Complete blood Count
                     5.6.3.2. CA-125 blood test
     5.7. Market Size (US$ Mn) Forecast By Test Type, 2018-2026
            5.7.1. Ultrasound Scanning
                     5.7.1.1.1. Abdominal Ultrasound
                     5.7.1.1.2. Transvaginal Ultrasound
            5.7.2. Biopsy
                     5.7.2.1. Endometrial Biopsy
                     5.7.2.2. Hysteroscopy
                     5.7.2.3. Dilation and curettage
            5.7.3. Blood tests
                     5.7.3.1. Complete blood Count
                     5.7.3.2. CA-125 blood test
     5.8. Historical Market Size Analysis 2013–2017, By End User
            5.8.1. Hospitals
            5.8.2. Ambulatory Surgical Centers
            5.8.3. Cancer Research Centers
            5.8.4. Specialized Clinics
            5.8.5. Diagnostic Laboratories
            5.8.6. Others
     5.9. Market Size Analysis 2018–2026, By End User
            5.9.1. Hospitals
            5.9.2. Ambulatory Surgical Centers
            5.9.3. Cancer Research Centers
            5.9.4. Specialized Clinics
            5.9.5. Diagnostic Laboratories
            5.9.6. Others
     5.10. Drivers and Restraints: Impact Analysis
     5.11. Market Attractiveness Analysis
            5.11.1. By Cancer Type
            5.11.2. By Test Type
            5.11.3. By End user
            5.11.4. By Country

6.  Latin America Uterine Cancer Diagnostic Testing Market Analysis 2013–2017 and Forecast 2018–2026
     6.1. Introduction
     6.2. Historical Market Size (US$ Mn) By Country, 2013-2017
            6.2.1. Brazil
            6.2.2. Mexico
            6.2.3. Rest of Latin America
     6.3. Market Size (US$ Mn) Forecast By Country, 2018-2026
            6.3.1. Brazil
            6.3.2. Mexico
            6.3.3. Rest of Latin America
     6.4. Historical Market Size (US$ Mn) By Cancer Type, 2013-2017
            6.4.1. Uterine Sarcoma
            6.4.2. Endometrial Carcinomas
     6.5. Market Size (US$ Mn) Forecast By Cancer Type, 2018-2026
            6.5.1. Uterine Sarcoma
            6.5.2. Endometrial Carcinomas
     6.6. Historical Market Size (US$ Mn) By Test Type, 2013-2017
            6.6.1. Ultrasound Scanning
                     6.6.1.1.1. Abdominal Ultrasound
                     6.6.1.1.2. Transvaginal Ultrasound
            6.6.2. Biopsy
                     6.6.2.1.1. Endometrial Biopsy
                     6.6.2.1.2. Hysteroscopy
                     6.6.2.1.3. Dilation and curettage
            6.6.3. Blood tests
                     6.6.3.1.1. Complete blood Count
                     6.6.3.1.2. CA-125 blood test
     6.7. Market Size (US$ Mn) Forecast By Test Type, 2018-2026
            6.7.1. Ultrasound Scanning
                     6.7.1.1.1. Abdominal Ultrasound
                     6.7.1.1.2. Transvaginal Ultrasound
            6.7.2. Biopsy
                     6.7.2.1.1. Endometrial Biopsy
                     6.7.2.1.2. Hysteroscopy
                     6.7.2.1.3. Dilation and curettage
            6.7.3. Blood tests
                     6.7.3.1.1. Complete blood Count
                     6.7.3.1.2. CA-125 blood test
     6.8. Historical Market Size Analysis 2013–2017, By End User
            6.8.1. Hospitals
            6.8.2. Ambulatory Surgical Centers
            6.8.3. Cancer Research Centers
            6.8.4. Specialized Clinics
            6.8.5. Diagnostic Laboratories
            6.8.6. Others
     6.9. Market Size Analysis 2018–2026, By End User
            6.9.1. Hospitals
            6.9.2. Ambulatory Surgical Centers
            6.9.3. Cancer Research Centers
            6.9.4. Specialized Clinics
            6.9.5. Diagnostic Laboratories
            6.9.6. Others
     6.10. Drivers and Restraints: Impact Analysis
     6.11. Market Attractiveness Analysis
            6.11.1. By Cancer Type
            6.11.2. By Test Type
            6.11.3. By End user
            6.11.4. By Country

7. Europe Uterine Cancer Diagnostic Testing Market Analysis 2013–2017 and Forecast 2018–2026
     7.1. Introduction
     7.2. Historical Market Size (US$ Mn) By Country, 2013-2017
            7.2.1. Germany
            7.2.2. U.K.
            7.2.3. France
            7.2.4. Italy
            7.2.5. Spain
            7.2.6. Poland
            7.2.7. Russia
            7.2.8. Rest of Europe
     7.3. Market Size (US$ Mn) Forecast By Country, 2018-2026
            7.3.1. Germany
            7.3.2. U.K.
            7.3.3. France
            7.3.4. Italy
            7.3.5. Spain
            7.3.6. Poland
            7.3.7. Russia
            7.3.8. Rest of Europe
     7.4. Historical Market Size (US$ Mn) By Cancer Type, 2013-2017
            7.4.1. Uterine Sarcoma
            7.4.2. Endometrial Carcinomas
     7.5. Market Size (US$ Mn) Forecast By Cancer Type, 2018-2026
            7.5.1. Uterine Sarcoma
            7.5.2. Endometrial Carcinomas
     7.6. Historical Market Size (US$ Mn) By Test Type, 2013-2017
            7.6.1. Ultrasound Scanning
                     7.6.1.1.1. Abdominal Ultrasound
                     7.6.1.1.2. Transvaginal Ultrasound
            7.6.2. Biopsy
                     7.6.2.1.1. Endometrial Biopsy
                     7.6.2.1.2. Hysteroscopy
                     7.6.2.1.3. Dilation and curettage
            7.6.3. Blood tests
                     7.6.3.1.1. Complete blood Count
                     7.6.3.1.2. CA-125 blood test
     7.7. Market Size (US$ Mn) Forecast By Test Type, 2018-2026
            7.7.1. Ultrasound Scanning
                     7.7.1.1.1. Abdominal Ultrasound
                     7.7.1.1.2. Transvaginal Ultrasound
            7.7.2. Biopsy
                     7.7.2.1.1. Endometrial Biopsy
                     7.7.2.1.2. Hysteroscopy
                     7.7.2.1.3. Dilation and curettage
            7.7.3. Blood tests
                     7.7.3.1.1. Complete blood Count
                     7.7.3.1.2. CA-125 blood test
     7.8. Historical Market Size Analysis 2013–2017, By End User
            7.8.1. Hospitals
            7.8.2. Ambulatory Surgical Centers
            7.8.3. Cancer Research Centers
            7.8.4. Specialized Clinics
            7.8.5. Diagnostic Laboratories
            7.8.6. Others
     7.9. Market Size Analysis 2018–2026, By End User
            7.9.1. Hospitals
            7.9.2. Ambulatory Surgical Centers
            7.9.3. Cancer Research Centers
            7.9.4. Specialized Clinics
            7.9.5. Diagnostic Laboratories
            7.9.6. Others
     7.10. Drivers and Restraints: Impact Analysis
     7.11. Market Attractiveness Analysis
            7.11.1. By Cancer Type
            7.11.2. By Test Type
            7.11.3. By End user
            7.11.4. By Country

8. Asia Pacific Excluding China Uterine Cancer Diagnostic Testing Market Analysis 2013–2017 and Forecast 2018–2026
     8.1. Introduction
     8.2. Historical Market Size (US$ Mn) By Country, 2013-2017
            8.2.1. China
            8.2.2. India
            8.2.3. Japan
            8.2.4. Australia and New Zealand
            8.2.5. Rest of APAC
     8.3. Market Size (US$ Mn) Forecast By Country, 2018-2026
            8.3.1. China
            8.3.2. India
            8.3.3. Japan
            8.3.4. Australia and New Zealand
            8.3.5. Rest of APAC
     8.4. Historical Market Size (US$ Mn) By Cancer Type, 2013-2017
            8.4.1. Uterine Sarcoma
            8.4.2. Endometrial Carcinomas
     8.5. Market Size (US$ Mn) Forecast By Cancer Type, 2018-2026
            8.5.1. Uterine Sarcoma
            8.5.2. Endometrial Carcinomas
     8.6. Historical Market Size (US$ Mn) By Test Type, 2013-2017
            8.6.1. Ultrasound Scanning
                     8.6.1.1.1. Abdominal Ultrasound
                     8.6.1.1.2. Transvaginal Ultrasound
            8.6.2. Biopsy
                     8.6.2.1.1. Endometrial Biopsy
                     8.6.2.1.2. Hysteroscopy
                     8.6.2.1.3. Dilation and curettage
            8.6.3. Blood tests
                     8.6.3.1.1. Complete blood Count
                     8.6.3.1.2. CA-125 blood test
     8.7. Market Size (US$ Mn) Forecast By Test Type, 2018-2026
            8.7.1. Ultrasound Scanning
                     8.7.1.1.1. Abdominal Ultrasound
                     8.7.1.1.2. Transvaginal Ultrasound
            8.7.2. Biopsy
                     8.7.2.1.1. Endometrial Biopsy
                     8.7.2.1.2. Hysteroscopy
                     8.7.2.1.3. Dilation and curettage
            8.7.3. Blood tests
                     8.7.3.1.1. Complete blood Count
                     8.7.3.1.2. CA-125 blood test
     8.8. Historical Market Size Analysis 2013–2017, By End User
            8.8.1. Hospitals
            8.8.2. Ambulatory Surgical Centers
            8.8.3. Cancer Research Centers
            8.8.4. Specialized Clinics
            8.8.5. Diagnostic Laboratories
            8.8.6. Others
     8.9. Market Size Analysis 2018–2026, By End User
            8.9.1. Hospitals
            8.9.2. Ambulatory Surgical Centers
            8.9.3. Cancer Research Centers
            8.9.4. Specialized Clinics
            8.9.5. Diagnostic Laboratories
            8.9.6. Others
     8.10. Drivers and Restraints: Impact Analysis
     8.11. Market Attractiveness Analysis
            8.11.1. By Cancer Type
            8.11.2. By Test Type
            8.11.3. By End user
            8.11.4. By Country

9. China Uterine Cancer Diagnostic Testing Market Analysis 2013–2017 and Forecast 2018–2026
     9.1. Introduction
     9.2. Historical Market Size (US$ Mn) By Cancer Type, 2013-2017
            9.2.1. Uterine Sarcoma
            9.2.2. Endometrial Carcinomas
     9.3. Market Size (US$ Mn) Forecast By Cancer Type, 2018-2026
            9.3.1. Uterine Sarcoma
            9.3.2. Endometrial Carcinomas
     9.4. Historical Market Size (US$ Mn) By Test Type, 2013-2017
            9.4.1. Ultrasound Scanning
                     9.4.1.1.1. Abdominal Ultrasound
                     9.4.1.1.2. Transvaginal Ultrasound
            9.4.2. Biopsy
                     9.4.2.1.1. Endometrial Biopsy
                     9.4.2.1.2. Hysteroscopy
                     9.4.2.1.3. Dilation and curettage
            9.4.3. Blood tests
                     9.4.3.1.1. Complete blood Count
                     9.4.3.1.2. CA-125 blood test
     9.5. Market Size (US$ Mn) Forecast By Test Type, 2018-2026
            9.5.1. Ultrasound Scanning
                     9.5.1.1.1. Abdominal Ultrasound
                     9.5.1.1.2. Transvaginal Ultrasound
            9.5.2. Biopsy
                     9.5.2.1.1. Endometrial Biopsy
                     9.5.2.1.2. Hysteroscopy
                     9.5.2.1.3. Dilation and curettage
            9.5.3. Blood tests
                     9.5.3.1.1. Complete blood Count
                     9.5.3.1.2. CA-125 blood test
     9.6. Historical Market Size Analysis 2013–2017, By End User
            9.6.1. Hospitals
            9.6.2. Ambulatory Surgical Centers
            9.6.3. Cancer Research Centers
            9.6.4. Specialized Clinics
            9.6.5. Diagnostic Laboratories
            9.6.6. Others
     9.7. Market Size Analysis 2018–2026, By End User
            9.7.1. Hospitals
            9.7.2. Ambulatory Surgical Centers
            9.7.3. Cancer Research Centers
            9.7.4. Specialized Clinics
            9.7.5. Diagnostic Laboratories
            9.7.6. Others
     9.8. Drivers and Restraints: Impact Analysis
     9.9. Market Attractiveness Analysis
            9.9.1. By Cancer Type
            9.9.2. By Test Type
            9.9.3. By End user
            9.9.4. By Country

10.  Middle East and Africa (MEA) Uterine Cancer Diagnostic Testing Market Analysis 2013–2017 and Forecast 2018–2026
     10.1. Introduction
     10.2. Historical Market Size (US$ Mn) By Country, 2013-2017
            10.2.1. South Africa
            10.2.2. Saudi Arabia
            10.2.3. Rest of MEA
     10.3. Market Size (US$ Mn) Forecast By Country, 2018-2026
            10.3.1. South Africa
            10.3.2. Saudi Arabia
            10.3.3. Rest of MEA
     10.4. Historical Market Size (US$ Mn) By Cancer Type, 2013-2017
            10.4.1. Uterine Sarcoma
            10.4.2. Endometrial Carcinomas
     10.5. Market Size (US$ Mn) Forecast By Cancer Type, 2018-2026
            10.5.1. Uterine Sarcoma
            10.5.2. Endometrial Carcinomas
     10.6. Historical Market Size (US$ Mn) By Test Type, 2013-2017
            10.6.1. Ultrasound Scanning
                     10.6.1.1.1. Abdominal Ultrasound
                     10.6.1.1.2. Transvaginal Ultrasound
            10.6.2. Biopsy
                     10.6.2.1.1. Endometrial Biopsy
                     10.6.2.1.2. Hysteroscopy
                     10.6.2.1.3. Dilation and curettage
            10.6.3. Blood tests
                     10.6.3.1.1. Complete blood Count
                     10.6.3.1.2. CA-125 blood test
     10.7. Market Size (US$ Mn) Forecast By Test Type, 2018-2026
            10.7.1. Ultrasound Scanning
                     10.7.1.1.1. Abdominal Ultrasound
                     10.7.1.1.2. Transvaginal Ultrasound
            10.7.2. Biopsy
                     10.7.2.1.1. Endometrial Biopsy
                     10.7.2.1.2. Hysteroscopy
                     10.7.2.1.3. Dilation and curettage
            10.7.3. Blood tests
                     10.7.3.1.1. Complete blood Count
                     10.7.3.1.2. CA-125 blood test
     10.8. Historical Market Size Analysis 2013–2017, By End User
            10.8.1. Hospitals
            10.8.2. Ambulatory Surgical Centers
            10.8.3. Cancer Research Centers
            10.8.4. Specialized Clinics
            10.8.5. Diagnostic Laboratories
            10.8.6. Others
     10.9. Market Size Analysis 2018–2026, By End User
            10.9.1. Hospitals
            10.9.2. Ambulatory Surgical Centers
            10.9.3. Cancer Research Centers
            10.9.4. Specialized Clinics
            10.9.5. Diagnostic Laboratories
            10.9.6. Others
     10.10. Drivers and Restraints: Impact Analysis
     10.11. Market Attractiveness Analysis
            10.11.1. By Cancer Type
            10.11.2. By Test Type
            10.11.3. By End user
            10.11.4. By Country

11.  Forecast Factors: Relevance and Impact

12.  Competition Landscape
     12.1. Competition Dashboard
     12.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
     12.3. Key Players
            12.3.1. Abbott
            12.3.2. Roche Holdings AG
            12.3.3. Siemens AG
            12.3.4. Danaher
            12.3.5. BioMerieux SA

13.  Global Uterine Cancer Diagnostic Testing Market Analysis 2013–2017 and Forecast 2018–2026, By Region
     13.1. Introduction
            13.1.1. Basis Point Share (BPS) Analysis by Region
            13.1.2. Y-o-Y Growth Projections by Region
     13.2. Historical Market Size Analysis 2013–2017, By Region
            13.2.1. North America
            13.2.2. Latin America
            13.2.3. Europe
            13.2.4. Asia Pacific Excluding China
            13.2.5. China
            13.2.6. Middle East and Africa (MEA)
     13.3. Market Size Analysis 2018–2026, By Region
            13.3.1. North America
            13.3.2. Latin America
            13.3.3. Europe
            13.3.4. Asia Pacific Excluding China
            13.3.5. China
            13.3.6. Middle East and Africa (MEA)
     13.4. Market Attractiveness Analysis by Region

14.  Global Uterine Cancer Diagnostic Testing Market Analysis 2013–2017 and Forecast 2018–2026, By Cancer Type
     14.1. Introduction
            14.1.1. Basis Point Share (BPS) Analysis by Product Type
            14.1.2. Y-o-Y Growth Projections by Product Type
     14.2. Historical Market Size Analysis 2013–2017, By Cancer Type
            14.2.1. Uterine Sarcoma
            14.2.2. Endometrial Carcinomas
     14.3. Market Size Analysis 2018–2026, By Cancer Type
            14.3.1. Uterine Sarcoma
            14.3.2. Endometrial Carcinomas
     14.4. Market Attractiveness Analysis by Cancer Type

15.  Global Uterine Cancer Diagnostic Testing Market Analysis 2013–2017 and Forecast 2018–2026, By Diagnostic Test Type
     15.1. Introduction
            15.1.1. Basis Point Share (BPS) Analysis by Test Type
            15.1.2. Y-o-Y Growth Projections by Test Type
     15.2. Historical Market Size Analysis 2013–2017, By Test Type
            15.2.1. Ultrasound Scanning
                     15.2.1.1.1. Abdominal Ultrasound
                     15.2.1.1.2. Transvaginal Ultrasound
            15.2.2. Biopsy
                     15.2.2.1.1. Endometrial Biopsy
                     15.2.2.1.2. Hysteroscopy
                     15.2.2.1.3. Dilation and curettage
            15.2.3. Blood tests
                     15.2.3.1.1. Complete blood Count
                     15.2.3.1.2. CA-125 blood test
     15.3. Market Size Analysis 2018–2026, By Test Type
            15.3.1. Ultrasound Scanning
                     15.3.1.1.1. Abdominal Ultrasound
                     15.3.1.1.2. Transvaginal Ultrasound
            15.3.2. Biopsy
                     15.3.2.1.1. Endometrial Biopsy
                     15.3.2.1.2. Hysteroscopy
                     15.3.2.1.3. Dilation and curettage
            15.3.3. Blood tests
                     15.3.3.1.1. Complete blood Count
                     15.3.3.1.2. CA-125 blood test
     15.4. Market Attractiveness Analysis by Test Type

16.  Global Uterine Cancer Diagnostic Testing Market Analysis 2013–2017 and Forecast 2018–2026, By End User
     16.1. Introduction
            16.1.1. Basis Point Share (BPS) Analysis by End User
            16.1.2. Y-o-Y Growth Projections by End User
     16.2. Historical Market Size Analysis 2013–2017, By End User
            16.2.1. Hospitals
            16.2.2. Ambulatory Surgical Centers
            16.2.3. Cancer Research Centers
            16.2.4. Specialized Clinics
            16.2.5. Diagnostic Laboratories
            16.2.6. Others
     16.3. Market Size Analysis 2018–2026, By End User
            16.3.1. Hospitals
            16.3.2. Ambulatory Surgical Centers
            16.3.3. Cancer Research Centers
            16.3.4. Specialized Clinics
            16.3.5. Diagnostic Laboratories
            16.3.6. Others
     16.4. Market Attractiveness Analysis by End User

17. Global Uterine Cancer Diagnostic Testing Market Analysis 2013–2017 and Forecast 2017–2027
     17.1. Market Size and Y-o-Y Growth
     17.2. Absolute $ Opportunity

18.  Assumptions and Acronyms Used
A glossary of assumption and acronyms used in the report

19.  Research Methodology

Find Out More about the Report Coverage

List of Tables

List of Tables

Table 1: North America Uterine Cancer Diagnostic Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 2: North America Uterine Cancer Diagnostic Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cancer Type
Table 3: North America Uterine Cancer Diagnostic Testing Fraction Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Diagnostic Test Type
Table 4: North America Uterine Cancer Diagnostic Testing Fraction Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End-Users
Table 5: Latin America Uterine Cancer Diagnostic Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 6: Latin America Uterine Cancer Diagnostic Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cancer Type
Table 7: Latin America Uterine Cancer Diagnostic Testing Fraction Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Diagnostic Test Type
Table 8: Latin America Uterine Cancer Diagnostic Testing Fraction Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End-Users
Table 9: Europe Uterine Cancer Diagnostic Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 10: Europe Uterine Cancer Diagnostic Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cancer Type
Table 11: Europe Uterine Cancer Diagnostic Testing Fraction Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Diagnostic Test Type
Table 12: Europe Uterine Cancer Diagnostic Testing Fraction Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End-Users
Table 13: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 14: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cancer Type
Table 15: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Fraction Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Diagnostic Test Type
Table 16: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Fraction Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End-Users
Table 17: China Uterine Cancer Diagnostic Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 18: China Uterine Cancer Diagnostic Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cancer Type
Table 19: China Uterine Cancer Diagnostic Testing Fraction Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Diagnostic Test Type
Table 20: China Uterine Cancer Diagnostic Testing Fraction Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End-Users
Table 21: Middle East and Africa Uterine Cancer Diagnostic Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 22: Middle East and Africa Uterine Cancer Diagnostic Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cancer Type
Table 23: Middle East and Africa Uterine Cancer Diagnostic Testing Fraction Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Diagnostic Test Type
Table 24: Middle East and Africa Uterine Cancer Diagnostic Testing Fraction Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End-Users
Table 25: Global Uterine Cancer Diagnostic Testing Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Region
Table 26: Global Uterine Cancer Diagnostic Testing Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Cancer Type
Table 27: Global Uterine Cancer Diagnostic Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Diagnostic Test Type
Table 28: Global Uterine Cancer Diagnostic Testing Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By End User

Explore Persistence Market Research’s expertise in promulgation of the business !

List of Chart

List of Figures

Figure 1: Global Uterine Cancer Diagnostic Testing Market Share by Cancer Type (2017)
Figure 2: Global Uterine Cancer Diagnostic Testing Market Share by Diagnostic Test Type (2017)
Figure 3: Global Uterine Cancer Diagnostic Testing Market Share by End User (2017)
Figure 4: Global Uterine Cancer Diagnostic Testing Market Share by Region (2017)
Figure 5: Percentage share of uterine cancer type
Figure 6: Percentage share of diagnostic test type
Figure 7: Regional Average Pricing Analysis (US$) of Abdominal Ultrasound Scanning (2017)
Figure 8: Regional Average Pricing Analysis (US$) of Transvaginal Ultrasound Scanning (2017)
Figure 9: Regional Average Pricing Analysis (US$) of Endometrial Biopsy (2017)
Figure 10: Regional Average Pricing Analysis (US$) of Hysteroscopy (2017)
Figure 11: Regional Average Pricing Analysis (US$) of Dilation & Curettage (2017)
Figure 12: Regional Average Pricing Analysis (US$) of Complete Blood Count (2017)
Figure 13: Regional Average Pricing Analysis (US$) of CA125 Tumor marker Blood Test (2017)
Figure 14: North America Uterine Cancer Diagnostic Testing Market Value Share, By Country (2017)
Figure 15: North America Uterine Cancer Diagnostic Testing Market Value Share, By Cancer Type (2017)
Figure 16: North America Uterine Cancer Diagnostic Testing Market Value Share, By Diagnostic Test Type (2017)
Figure 17: North America Uterine Cancer Diagnostic Testing Market Value Share, By End-Users (2017)
Figure 18: North America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013-2017
Figure 19: North America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 20: U.S. Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013–2017
Figure 21: U.S. Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 22: Canada Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013–2017
Figure 23: Canada Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 24: North America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Endometrial Carcinoma, 2013–2017
Figure 25: North America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Endometrial Carcinoma, 2018–2026
Figure 26: North America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Uterine Sarcoma, 2013–2017
Figure 27: North America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Uterine Sarcoma, 2018–2026
Figure 28: North America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, by Ultrasound Scanning, 2013–2017
Figure 29: North America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), by Ultrasound Scanning 2018–2026
Figure 30: North America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, by Biopsy Procedure, 2013–2017
Figure 31: North America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), by Biopsy Procedure, 2018–2026
Figure 32: North America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, by Blood Test, 2013–2017
Figure 33: North America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), by Blood Test 2018–2026
Figure 34: North America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Hospitals, and 2013–2017
Figure 35: North America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Hospitals, 2018–2026
Figure 36: North America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Ambulatory Surgical Centers, and 2013–2017
Figure 37: North America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Ambulatory Surgical Centers, 2018–2026
Figure 38: North America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Cancer Research Institutes, 2013–2017
Figure 39: North America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Cancer Research Institutes, 2018–2026
Figure 40: North America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Specialized Clinics, and 2013–2017
Figure 41: North America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Specialized Clinics, 2018–2026
Figure 42: North America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Diagnostic Laboratories, and 2013–2017
Figure 43: North America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Diagnostic Laboratories, 2018–2026
Figure 44: North America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Others, 2013–2017
Figure 45: North America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Others, 2018–2026
Figure 46: North America Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By Country
Figure 47: North America Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By Cancer Type
Figure 48: North America Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By Diagnostic Test Type
Figure 49: North America Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By End-User
Figure 50: Latin America Uterine Cancer Diagnostic Testing Market Value Share, By Country (2017)
Figure 51: Latin America Uterine Cancer Diagnostic Testing Market Value Share, By Cancer Type (2017)
Figure 52: Latin America Uterine Cancer Diagnostic Testing Market Value Share, By Diagnostic Test Type (2017)
Figure 53: Latin America Uterine Cancer Diagnostic Testing Market Value Share, By End-Users (2017)
Figure 54: Latin America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013-2017
Figure 55: Latin America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 56: Brazil Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013–2017
Figure 57: Brazil Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 58: Mexico Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013–2017
Figure 59: Mexico Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 60: Rest of Latin America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013–2017
Figure 61: Rest of Latin America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 62: Latin America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Endometrial Carcinoma, 2013–2017
Figure 63: Latin America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Endometrial Carcinoma, 2018–2026
Figure 64: Latin America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Uterine Sarcoma, 2013–2017
Figure 65: Latin America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Uterine Sarcoma, 2018–2026
Figure 66: Latin America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, by Ultrasound Scanning, 2013–2017
Figure 67: Latin America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), by Ultrasound Scanning, 2018–2026
Figure 68: Latin America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, by Biopsy Procedure, 2013–2017
Figure 69: Latin America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), by Biopsy Procedure, 2018–2026
Figure 70: Latin America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, by Blood Test, 2013–2017
Figure 71: Latin America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), by Blood Test 2018–2026
Figure 72: Latin America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Hospitals, and 2013–2017
Figure 73: Latin America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Hospitals, 2018–2026
Figure 74: Latin America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Ambulatory Surgical Centers, and 2013–2017
Figure 75: Latin America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Ambulatory Surgical Centers, 2018–2026
Figure 76: Latin America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Cancer Research Institutes, 2013–2017
Figure 77: Latin America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Cancer Research Institutes, 2017–2026
Figure 78: Latin America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Specialized Clinics, and 2013–2017
Figure 79: Latin America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Specialized Clinics, 2017–2026
Figure 80: Latin America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Diagnostic Laboratories, and 2013–2017
Figure 81: Latin America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Diagnostic Laboratories, 2017–2026
Figure 82: Latin America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Others, 2013–2017
Figure 83: Latin America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Others, 2017–2026
Figure 84: Latin America Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By Country
Figure 85: Latin America Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By Cancer Type
Figure 86: Latin America Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By Diagnostic Test Type
Figure 87: Latin America Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By End-User
Figure 88: Europe Uterine Cancer Diagnostic Testing Market Value Share, By Country (2017)
Figure 89: Europe Uterine Cancer Diagnostic Testing Market Value Share, By Cancer Type (2017)
Figure 90: Europe Uterine Cancer Diagnostic Testing Market Value Share, By Diagnostic Test Type (2017)
Figure 91: Europe Uterine Cancer Diagnostic Testing Market Value Share, By End-Users (2017)
Figure 92: Europe Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013-2017
Figure 93: Europe Uterine Cancer Diagnostic Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 94: Russia Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013–2017
Figure 95: Russia Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 96: Germany Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013–2017
Figure 97: Germany Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 98: U.K Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013–2017
Figure 99: U.K Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 100: France Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013–2017
Figure 101: France Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 102: Italy Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013–2017
Figure 103: Italy Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 104: Poland Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013–2017
Figure 105: Poland Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 106: Spain Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013–2017
Figure 107: Spain Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 108: Rest of Europe Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013–2017
Figure 109: Rest of Europe Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 110: Europe Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Endometrial Carcinoma, 2013–2017
Figure 111: Europe Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Endometrial Carcinoma, 2018–2026
Figure 112: Europe Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Uterine Sarcoma, 2013–2017
Figure 113: Europe Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Uterine Sarcoma, 2018–2026
Figure 114: Europe Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, by Ultrasound Scanning, 2013–2017
Figure 115: Europe Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), by Ultrasound Scanning2018–2026
Figure 116: Europe Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, by Biopsy Procedure, 2013–2017
Figure 117: Europe Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), by Biopsy Procedure, 2018–2026
Figure 118: Europe Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, by Blood Test, 2013–2017
Figure 119: Europe Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), by Blood Test 2017–2026
Figure 120: Europe Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Hospitals, and 2013–2017
Figure 121: Europe Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Hospitals, 2018–2026
Figure 122: Europe Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Ambulatory Surgical Centers, and 2013–2017
Figure 123: Europe Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Ambulatory Surgical Centers, 2018–2026
Figure 124: Europe Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Cancer Research Institutes, 2013–2017
Figure 125: Europe Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Cancer Research Institutes, 2018–2026
Figure 126: Europe Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Specialized Clinics, and 2013–2017
Figure 127: Europe Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Specialized Clinics, 2018–2026
Figure 128: Europe Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Diagnostic Laboratories, and 2013–2017
Figure 129: Europe Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Diagnostic Laboratories, 2018–2026
Figure 130: Europe Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Others, 2013–2017
Figure 131: Europe Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Others, 2018–2026
Figure 132: Europe Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By Country
Figure 133: Europe Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By Cancer Type
Figure 134: Europe Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By Diagnostic Test Type
Figure 135: Europe Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By End-User
Figure 136: Asia-Pacific Excluding China Uterine Cancer Diagnostic Testing Market Value Share, By Country (2017)
Figure 137: Asia-Pacific Excluding China Uterine Cancer Diagnostic Testing Market Value Share, By Cancer Type (2017)
Figure 138: Asia-Pacific Excluding China Uterine Cancer Diagnostic Testing Market Value Share, By Diagnostic Test Type (2017)
Figure 139: Asia-Pacific Excluding China Uterine Cancer Diagnostic Testing Market Value Share, By End-Users (2017)
Figure 140: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013-2017
Figure 141: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 142: India Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013–2017
Figure 143: India Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 144: Japan Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013–2017
Figure 145: Japan Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 146: ASEAN Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013–2017
Figure 147: ASEAN Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 148: Australia and New Zealand Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013–2017
Figure 149: Australia and New Zealand Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 150: Rest of Asia-Pacific Excluding China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013–2017
Figure 151: Rest of Asia-Pacific Excluding China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 152: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Endometrial Carcinoma, 2013–2017
Figure 153: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Endometrial Carcinoma, 2018–2026
Figure 154: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Uterine Sarcoma, 2013–2017
Figure 155: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Uterine Sarcoma, 2018–2026
Figure 156: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, by Ultrasound Scanning, 2013–2017
Figure 157: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), by Ultrasound Scanning, 2018–2026
Figure 158: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, by Biopsy Procedure, 2013–2017
Figure 159: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), by Biopsy Procedure, 2018–2026
Figure 160: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, by Blood Test, 2013–2017
Figure 161: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), by Blood Test 2018–2026
Figure 162: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Hospitals, and 2013–2017
Figure 163: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Hospitals, 2018–2026
Figure 164: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Ambulatory Surgical Centers, 2013–2017
Figure 165: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Ambulatory Surgical Centers, 2018–2026
Figure 166: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Cancer Research Institutes, and 2013–2017
Figure 167: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Cancer Research Institutes, 2018–2026
Figure 168: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Specialized Clinics, and 2013–2017
Figure 169: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Specialized Clinics, 2018–2026
Figure 170: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Diagnostic Laboratories, and 2013–2017
Figure 171: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Diagnostic Laboratories, 2018–2026
Figure 172: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Others, 2013–2017
Figure 173: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), others, 2018–2026
Figure 174: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By Country
Figure 175: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By Cancer Type
Figure 176: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By Diagnostic Test Type
Figure 177: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By End-User
Figure 178: China Uterine Cancer Diagnostic Testing Market Value Share, By Cancer Type (2017)
Figure 179: China Uterine Cancer Diagnostic Testing Market Value Share, By Diagnostic Test Type (2017)
Figure 180: China Uterine Cancer Diagnostic Testing Market Value Share, By End-Users (2017)
Figure 181: China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013-2017
Figure 182: China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 183: China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Endometrial Carcinoma, 2013–2017
Figure 184: China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Endometrial Carcinoma, 2018–2026
Figure 185: China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Uterine Sarcoma, 2013–2017
Figure 186: China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Uterine Sarcoma, 2018–2026
Figure 187: China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, by Ultrasound Scanning, 2013–2017
Figure 188: China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), by Ultrasound Scanning, 2018–2026
Figure 189: China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, by Biopsy Procedure, 2013–2017
Figure 190: China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), by Biopsy Procedure, 2018–2026
Figure 191: China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, by Blood Test, 2013–2017
Figure 192: China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), by Blood Test 2018–2026
Figure 193: China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Hospitals, and 2013–2017
Figure 194: China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Hospitals, 2018–2026
Figure 195: China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Ambulatory Surgical Centers, and 2013–2017
Figure 196: China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Ambulatory Surgical Centers, 2018–2026
Figure 197: China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Cancer Research Institutes, 2013–2017
Figure 198: China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Cancer Research Institutes, 2017–2026
Figure 199: China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Specialized Clinics, and 2013–2017
Figure 200: China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Specialized Clinics, 2017–2026
Figure 201: China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Diagnostic Laboratories, and 2013–2017
Figure 202: China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Diagnostic Laboratories, 2018–2026
Figure 203: China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Others, 2013–2017
Figure 204: China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Others, 2018–2026
Figure 205: China Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By Cancer Type
Figure 206: China Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By Diagnostic Test Type
Figure 207: China Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By End-User
Figure 208: Middle East and Africa Uterine Cancer Diagnostic Testing Market Value Share, By Country (2017)
Figure 209: Middle East and Africa Uterine Cancer Diagnostic Testing Market Value Share, By Cancer Type (2017)
Figure 210: Middle East and Africa Uterine Cancer Diagnostic Testing Market Value Share, By Diagnostic Test Type (2017)
Figure 211: Middle East and Africa Uterine Cancer Diagnostic Testing Market Value Share, By End-Users (2017)
Figure 212: Middle East and Africa Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013-2017
Figure 213: Middle East and Africa Uterine Cancer Diagnostic Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 214: South Africa Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013–2017
Figure 215: South Africa Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 216: Saudi Arabia Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013–2017
Figure 217: Saudi Arabia Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 218: Rest of Middle East and Africa Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013–2017
Figure 219: Rest of Middle East and Africa Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 220: Middle East and Africa Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Endometrial Carcinoma, 2013–2017
Figure 221: Middle East and Africa Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Endometrial Carcinoma, 2018–2026
Figure 222: Middle East and Africa Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Uterine Sarcoma, 2013–2017
Figure 223: Middle East and Africa Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Uterine Sarcoma, 2018–2026
Figure 224: Middle East and Africa Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, by Ultrasound Scanning, 2013–2017
Figure 225: Middle East and Africa Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), by Ultrasound Scanning, 2018–2026
Figure 226: Middle East and Africa Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, by Biopsy Procedure, 2013–2017
Figure 227: Middle East and Africa Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), by Biopsy Procedure, 2018–2026
Figure 228: Middle East and Africa Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, by Blood Test, 2013–2017
Figure 229: Middle East and Africa Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), by Blood Test 2018–2026
Figure 230: Middle East and Africa Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Hospitals, and 2013–2017
Figure 231: Middle East and Africa Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Hospitals, 2018–2026
Figure 232: Middle East and Africa Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Ambulatory Surgical Centers, and 2013–2017
Figure 233: Middle East and Africa Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Ambulatory Surgical Centers, 2018–2026
Figure 234: Middle East and Africa Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Cancer Research Institutes, 2013–2017
Figure 235: Middle East and Africa Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Cancer Research Institutes, 2018–2026
Figure 236: Middle East and Africa Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Specialized Clinics, and 2013–2017
Figure 237: Middle East and Africa Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Specialized Clinics, 2018–2026
Figure 238: Middle East and Africa Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Diagnostic Laboratories, and 2013–2017
Figure 239: Middle East and Africa Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Diagnostic Laboratories, 2018–2026
Figure 240: Middle East and Africa Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Others, 2013–2017
Figure 241: Middle East and Africa Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Others, 2018–2026
Figure 242: Middle East and Africa Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By Country
Figure 243: Middle East and Africa Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By Cancer Type
Figure 244: Middle East and Africa Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By Diagnostic Test Type
Figure 245: Middle East and Africa Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By End-User
Figure 246: Global Uterine Cancer Diagnostic Testing Market Attractiveness Analysis by Region, 2018–2026
Figure 247: Global Uterine Cancer Diagnostic Testing Market Share Analysis (%) By Region, 2018 & 2026
Figure 248: Global Uterine Cancer Diagnostic Testing Market Y-o-Y Growth (%) By Region, 2018–2026
Figure 249: Global Uterine Cancer Diagnostic Testing Market Share Analysis (%) By Cancer Type, 2018 & 2026
Figure 250: Global Uterine Cancer Diagnostic Testing Market Y-o-Y Growth (%) By Cancer Type, 2018–2026
Figure 251: Global Uterine Cancer Diagnostic Testing Market Attractiveness Analysis by Cancer Type, 2018–2026
Figure 252: Global Uterine Cancer Diagnostic Testing Market Share Analysis (%) By Ultrasound Scanning, 2017 & 2026 
Figure 253: Global Uterine Cancer Diagnostic Testing Market Y-o-Y Growth (%) By Ultrasound Scanning, 2017–2026
Figure 254: Global Uterine Cancer Diagnostic Testing Market Share Analysis (%) By Biopsy Procedure, 2017 & 2026
Figure 255: Global Uterine Cancer Diagnostic Testing Market Share Analysis (%) By Biopsy Procedure, 2017 & 2026
Figure 256: Global Uterine Cancer Diagnostic Testing Market Share Analysis (%) By Blood Test, 2017 & 2026
Figure 257: Global Uterine Cancer Diagnostic Testing Market Y-o-Y Growth (%) By Blood Test, 2017–2026
Figure 258: Global Uterine Cancer Diagnostic Testing Market Attractiveness Analysis by Ultrasound Scanning, 2018–2026
Figure 259: Global Uterine Cancer Diagnostic Testing Market Attractiveness Analysis by Biopsy Procedure, 2018–2026
Figure 260: Global Uterine Cancer Diagnostic Testing Market Attractiveness Analysis by Blood Test, 2018–2026
Figure 261: Global Uterine Cancer Diagnostic Testing Market Attractiveness Analysis by End User, 2017–2026
Figure 262: Global Uterine Cancer Diagnostic Testing Market Share Analysis (%) By End User, 2017 & 2026
Figure 263: Global Uterine Cancer Diagnostic Testing Market Y-o-Y Growth (%) By End User, 2018–2026
Figure 264: Global Uterine Cancer Diagnostic Testing Market Value Analysis and Forecast, 2018–2026 (US$ Mn)
Figure 265: Global Uterine Cancer Diagnostic Testing Market Value (US$ Mn), 2013–2017
Figure 266: Global Uterine Cancer Diagnostic Testing Market Absolute $ Opportunity (US$ Mn), 2017–2026

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Description

Persistence Market Research offers an eight year forecast on the global Uterine Cancer Diagnostic Testing market. The primary objective of the report is to offer updates and information related to market opportunities in the Uterine Cancer Diagnostic Testing market.

Report Description

In terms of revenue, the global Uterine Cancer Diagnostic Testing market is expected to register a CAGR of 7.8% during the forecast period, 2018–2026. The primary objective of the report is to offer insights on the market dynamics that can influence the growth of the global Uterine Cancer Diagnostic Testing market over the forecast period. Insights on key trends, drivers, restraints, value forecasts and opportunities for companies operating in the global Uterine Cancer Diagnostic Testing market are presented in the report.

The global market for Uterine Cancer Diagnostic Testing is expected to witness high growth rate in terms of value in high economic countries due to increase in incidence of uterine cancer cases and efficient healthcare infrastructure. Increase in healthcare expenditure and rising women geriatric population has also driven the market for Uterine Cancer Diagnostic Testing. Low and Middle economy countries like India and South Africa have a lower incidence rate for uterine cancer. The diagnosis rate is poor in these countries and thus, these countries witness low growth rate in terms of value for Uterine Cancer Diagnostic Testing market.

The report includes Uterine Cancer Diagnostic Test types like ultrasound scanning, biopsy procedures and blood tests. Ultrasound scanning has further been segmented into abdominal ultrasound scanning and transvaginal ultrasound scanning. Biopsy procedures include endometrial biopsy, hysteroscopy and dilation & curettage. Blood tests include a complete blood count test, also known as CBC and CA125 marker blood test.

However, the report does not include revenue generated by the imaging procedures like CT scans, MRI scans, X-Rays, PET scans, endoscopy procedures and other screening & treatment methods. Currency fluctuations and inflation are not considered while calculating the revenue of the Uterine Cancer Diagnostic Testing market.

Revenue from the Uterine Cancer Diagnostic Testing market in North America is expected to expand at a relatively higher CAGR due to growing awareness of women health and gynaecologic cancer. High incidence rates also contribute to the market for Uterine Cancer Diagnostic Testing in the region. To understand and assess the opportunities in this market, the report offers the market forecast on the basis of segment type classified into the cancer type, diagnostic test type, end users and regions. The report provides analysis of the global Uterine Cancer Diagnostic Testing market in terms of market value (US$ Mn).

 

Recommendations

Asia Pacific North America Europe Fluorinated Solvents Market

The Asia Pacific Fluorinated Solvents market is expected to register a CAGR of 9.0% over the forecast period (2018–2026)..

Behenyl Alcohol Market

The behenyl alcohol market has seen steady demand from the cosmetics industry. Moreover, globally, per capita consumption of cosmetics is increasing at a rate of 3.4% per year.

Polyester Polyols Market

Polyester Polyols Market was valued at US$ 7,788.7 Mn in 2017 and is projected to rise to a valuation of US$ 11,963.6 Mn by the end of 2025..

Bismuth Market

Global bismuth market is estimated reach around US$ 225 Mn in 2016 and is projected to expand at a moderate single-digit CAGR in terms of value from 2016-2024.

Our Clients

Our Clients